RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates

20246 citationsJournal Articlegold Open Access

Authors

Asim Roy · Sleep Management Institute

Thomas Stern · New Century Pharmaceuticals (United States)

John Harsh · Colorado Sleep Institute

J Douglas Hudson · Futures Group (United States)

Akinyemi O. Ajayi · Center for Independent Living

Bruce Corser · Sleep Management Institute

Emmanuel Mignot

Abstract

The second nightly IR oxybate dose presents significant treatment burdens and adherence concerns. Participants overwhelmingly preferred the once-nightly dosing regimen of ON-SXB.

Topics & Keywords

Behavioral Health and Interventions Circadian rhythm and melatonin Olfactory and Sensory Function Studies

UN Sustainable Development Goals

Climate action

Publication Details

Published in: Sleep Medicine X

Volume 8, pp. 100122-100122

DOI: 10.1016/j.sleepx.2024.100122

Field-Weighted Citation Impact: 2.46